Update on the biology and treatment of lymphedema
- PMID: 22382848
- DOI: 10.1007/s11936-012-0170-0
Update on the biology and treatment of lymphedema
Abstract
The past decade has produced an explosion of insights into lymphatic vascular development and structural biology and, in parallel, into the function of the lymphatics in health and in disease. In lymphedema, there is a spectrum that extends from primary (heritable) to acquired causes of disease. The diagnosis of lymphatic edema implicates a very specific treatment approach that is predicated upon the favorable impact of physiotherapy upon lymph flow and protein clearance from the edematous zones of the body. The recognition of the unique biology that accompanies lymphatic causes of edema has stimulated new research directions that are likely to translate into exciting new pharmacologic and molecular approaches to diagnosis and treatment.
Similar articles
-
Current concepts and future directions in the diagnosis and management of lymphatic vascular disease.Vasc Med. 2010 Jun;15(3):223-31. doi: 10.1177/1358863X10364553. Vasc Med. 2010. PMID: 20483987 Review.
-
The unique biology of lymphatic edema.Lymphat Res Biol. 2009;7(2):97-100. doi: 10.1089/lrb.2009.7202. Lymphat Res Biol. 2009. PMID: 19522679
-
Anatomic and functional evaluation of the lymphatics and lymph nodes in diagnosis of lymphatic circulation disorders with contrast magnetic resonance lymphangiography.J Vasc Surg. 2009 Apr;49(4):980-7. doi: 10.1016/j.jvs.2008.11.029. Epub 2009 Feb 15. J Vasc Surg. 2009. PMID: 19223143
-
Lymphatic endothelial cells, lymphedematous lymphangiogenesis, and molecular control of edema formation.Lymphat Res Biol. 2008;6(3-4):123-37. doi: 10.1089/lrb.2008.1005. Lymphat Res Biol. 2008. PMID: 19093784 Review.
-
Lymphedema: A Practical Approach and Clinical Update.Wounds. 2020 Mar;32(3):86-92. Wounds. 2020. PMID: 32163039 Review.
Cited by
-
Blunted flow-mediated responses and diminished nitric oxide synthase expression in lymphatic thoracic ducts of a rat model of metabolic syndrome.Am J Physiol Heart Circ Physiol. 2016 Feb 1;310(3):H385-93. doi: 10.1152/ajpheart.00664.2015. Epub 2015 Dec 4. Am J Physiol Heart Circ Physiol. 2016. PMID: 26637560 Free PMC article.
-
Health-related quality of life outcomes for the LEAP study-CALGB 70305 (Alliance): A lymphedema prevention intervention trial for newly diagnosed breast cancer patients.Cancer. 2021 Jan 15;127(2):300-309. doi: 10.1002/cncr.33184. Epub 2020 Oct 20. Cancer. 2021. PMID: 33079393 Free PMC article. Clinical Trial.
-
VEGFR-3 neutralization inhibits ovarian lymphangiogenesis, follicle maturation, and murine pregnancy.Am J Pathol. 2013 Nov;183(5):1596-1607. doi: 10.1016/j.ajpath.2013.07.031. Epub 2013 Sep 13. Am J Pathol. 2013. PMID: 24036251 Free PMC article.
-
Local inhibition of elastase reduces EMILIN1 cleavage reactivating lymphatic vessel function in a mouse lymphoedema model.Clin Sci (Lond). 2016 Jul 1;130(14):1221-36. doi: 10.1042/CS20160064. Epub 2016 Feb 26. Clin Sci (Lond). 2016. PMID: 26920215 Free PMC article.
-
Transient swelling versus lymphoedema in the first year following surgery for breast cancer.Support Care Cancer. 2013 Aug;21(8):2207-15. doi: 10.1007/s00520-013-1770-2. Epub 2013 Mar 15. Support Care Cancer. 2013. PMID: 23494582 Clinical Trial.
References
LinkOut - more resources
Full Text Sources
Miscellaneous